Pro Life Clinics has been operating on the private medical services market in Iași for over 13 years and offers outpatient medical services that integrate 19 medical specialties: from allergology and clinical immunology, dermatology and cardiology, to endocrinology, medical imaging, internal medicine, neurology and others. In addition to outpatient medical services, Pro Life Clinics also provides 27-bed day hospitalization services for cardiology, diabetes, nutrition and metabolism, endocrinology, internal medicine, neurology, rheumatology.
Pro Life Clinics had a turnover of RON7.3 million in 2021, with 77% of the turnover being represented by outpatient services and 23% by day hospitalization services. All medical services are under contract with Iasi Health Insurance House.
“We are accelerating the consolidation of Sfânta Maria brand through a new transaction that takes place just 1 day after the full acquisition of Life Med. We come to patients in the area of Moldova with integrated medical services, which cover a wide range of medical specialties both outpatient and day hospitalization. In Iași, we have consolidated our presence by adding to our portfolio a new partner capable of ensuring correct diagnoses and treatments at European standards”, stated Mihai Marcu, President and CEO of MedLife Group.
Sfanta Maria medical brand was launched five years ago and has become one of the most important national health networks. It operates on the medical services market with over 60 own medical units, which resulted from the acquisition projects and organic developments, as follows: 14 clinics in Bucharest, Bacau, Galati, Magurele and Sibiu, ten laboratories in Bucharest, Braila, Bacau, Craiova, Galați and Sibiu, as well as over 30 collection points. At the same time, Saint Mary is among the operators with the largest own family medicine network.
Following the recent acquisition of the Life Med Clinic, the acquisition of Pro Life Clinics is the 38th transaction by MedLife Group.
MedLife reported a pro-forma consolidated turnover of EUR332 million in 2021, up 51% year-over-year, and announced plans for acquisitions and growth of EUR120 million, in line with the company’s financial report. MedLife’s net profit almost doubled in 2021 to RON123 million, up 93% year-over-year.
Medlife SA, a company listed on the Bucharest Stock Exchange, has a capitalization of RON2.9 billion. Its main shareholders are Mihai Marcu, 15.4%, Mihaela Cristescu, 14%, Nicolae Marcu, 10.5%, and Fondul de Pensii NN (pension fund), 12.8%.